Literature DB >> 19545502

Prevention counseling for HIV-infected persons: what every clinician needs to know.

Wayne A Duffus1, Ikechukwu U Ogbuanu.   

Abstract

The absence of adequate and regular prevention counseling during routine clinical encounters translates into missed opportunities for HIV prevention. HIV care providers have considerably more contact with patients than clinicians in other disciplines. These contacts should be translated into opportunities to provide HIV prevention messages to patients and should be a priority for all clinicians caring for HIV-positive patients. Coincidental preventive care for HIV-positive patients is inherently unproductive because of the absence of reinforcing messages. In a recent meta-analysis, HIV-positive individuals who underwent counseling and testing services reduced high-risk behaviors by about 68%. Prevention counseling should focus on positive reinforcement, harm reduction, education, and support. We strongly recommend regular, brief, targeted prevention counseling as a part of every clinical encounter.

Entities:  

Year:  2009        PMID: 19545502     DOI: 10.1007/s11908-009-0047-x

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  46 in total

1.  Association of antiretroviral therapy with detection of HIV-1 RNA and DNA in the anorectal mucosa of homosexual men.

Authors:  T M Lampinen; C W Critchlow; J M Kuypers; C S Hurt; P J Nelson; S E Hawes; R W Coombs; K K Holmes; N B Kiviat
Journal:  AIDS       Date:  2000-03-31       Impact factor: 4.177

2.  Sexually transmitted diseases in the HIV care setting: what's really going on down there?

Authors:  Jeanne Marrazzo
Journal:  Top HIV Med       Date:  2004 May-Jun

3.  Designing and delivering a prevention project within an HIV treatment setting: lessons learned from a specialist model.

Authors:  Christine Nollen; Mari-Lynn Drainoni; Victoria Sharp
Journal:  AIDS Behav       Date:  2007-06-19

4.  HIV superinfection: another reason to avoid serosorting practice.

Authors:  Krishna C Poudel; Kalpana Poudel-Tandukar; Junko Yasuoka; Masamine Jimba
Journal:  Lancet       Date:  2007-07-07       Impact factor: 79.321

5.  Estimation of HIV incidence in the United States.

Authors:  H Irene Hall; Ruiguang Song; Philip Rhodes; Joseph Prejean; Qian An; Lisa M Lee; John Karon; Ron Brookmeyer; Edward H Kaplan; Matthew T McKenna; Robert S Janssen
Journal:  JAMA       Date:  2008-08-06       Impact factor: 56.272

Review 6.  HIV disease progression: depression, stress, and possible mechanisms.

Authors:  Jane Leserman
Journal:  Biol Psychiatry       Date:  2003-08-01       Impact factor: 13.382

7.  Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. HIV testing and prevention strategies.

Authors:  Susan Buchbinder
Journal:  Top HIV Med       Date:  2008 Apr-May

Review 8.  Preconception health care for HIV-infected women.

Authors:  Erika Z Aaron; Shannon M Criniti
Journal:  Top HIV Med       Date:  2007 Aug-Sep

9.  Factors associated with engaging socially marginalized HIV-positive persons in primary care.

Authors:  Maureen H Rumptz; Carol Tobias; Serena Rajabiun; Judith Bradford; Howard Cabral; Robin Young; William E Cunningham
Journal:  AIDS Patient Care STDS       Date:  2007       Impact factor: 5.078

10.  Effect of physician specialty on counseling practices and medical referral patterns among physicians caring for disadvantaged human immunodeficiency virus-infected populations.

Authors:  W A Duffus; M Barragan; L Metsch; C S Krawczyk; A M Loughlin; L I Gardner; P Anderson-Mahoney; G Dickinson; C del Rio
Journal:  Clin Infect Dis       Date:  2003-06-05       Impact factor: 9.079

View more
  1 in total

1.  Comparison of missed opportunities for earlier HIV diagnosis in 3 geographically proximate emergency departments.

Authors:  Michael S Lyons; Christopher J Lindsell; D Beth Wayne; Andrew H Ruffner; Kimberly W Hart; Carl J Fichtenbaum; Alexander T Trott; Patrick S Sullivan
Journal:  Ann Emerg Med       Date:  2011-07       Impact factor: 5.721

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.